Zhaoshi Zeng

4.0k total citations
37 papers, 2.6k citations indexed

About

Zhaoshi Zeng is a scholar working on Oncology, Pathology and Forensic Medicine and Cancer Research. According to data from OpenAlex, Zhaoshi Zeng has authored 37 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 14 papers in Pathology and Forensic Medicine and 12 papers in Cancer Research. Recurrent topics in Zhaoshi Zeng's work include Genetic factors in colorectal cancer (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Liver physiology and pathology (6 papers). Zhaoshi Zeng is often cited by papers focused on Genetic factors in colorectal cancer (13 papers), Colorectal Cancer Treatments and Studies (12 papers) and Liver physiology and pathology (6 papers). Zhaoshi Zeng collaborates with scholars based in United States, China and Australia. Zhaoshi Zeng's co-authors include Philip B. Paty, Alfred M. Cohen, José G. Guillem, Jinru Shia, Martin R. Weiser, Leonard B. Saltz, Francis Barany, Mark Gimbel, Weiping Shu and Sohail F. Tavazoie and has published in prestigious journals such as Cell, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Zhaoshi Zeng

36 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoshi Zeng United States 27 1.3k 1.0k 897 686 415 37 2.6k
Roberta Pang Hong Kong 29 1.1k 0.8× 1.6k 1.5× 987 1.1× 383 0.6× 815 2.0× 53 3.0k
Camilla Pilati France 19 1.1k 0.8× 1.1k 1.1× 617 0.7× 440 0.6× 542 1.3× 32 2.7k
Belinda Cancilla United States 18 1.1k 0.9× 1.5k 1.5× 377 0.4× 309 0.5× 347 0.8× 38 2.7k
Yoshihiko Kitajima Japan 29 956 0.7× 1.6k 1.5× 836 0.9× 254 0.4× 181 0.4× 85 2.7k
Kaoru Mogushi Japan 29 756 0.6× 1.6k 1.6× 799 0.9× 270 0.4× 312 0.8× 93 2.7k
M Imamura Japan 27 1.2k 0.9× 1.5k 1.4× 720 0.8× 240 0.3× 310 0.7× 79 2.9k
Eric Santoni‐Rugiu Denmark 35 1.2k 0.9× 1.7k 1.7× 681 0.8× 232 0.3× 644 1.6× 108 3.3k
Binkui Li China 30 743 0.6× 1.3k 1.3× 950 1.1× 296 0.4× 932 2.2× 103 2.8k
Graham F. Barnard United States 25 1.5k 1.1× 1.6k 1.5× 756 0.8× 223 0.3× 308 0.7× 63 3.0k
Sara Toffanin United States 14 515 0.4× 1.2k 1.1× 793 0.9× 317 0.5× 890 2.1× 18 2.3k

Countries citing papers authored by Zhaoshi Zeng

Since Specialization
Citations

This map shows the geographic impact of Zhaoshi Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoshi Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoshi Zeng more than expected).

Fields of papers citing papers by Zhaoshi Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoshi Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoshi Zeng. The network helps show where Zhaoshi Zeng may publish in the future.

Co-authorship network of co-authors of Zhaoshi Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoshi Zeng. A scholar is included among the top collaborators of Zhaoshi Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoshi Zeng. Zhaoshi Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morris, Montana T., Abhishek Jain, Boshi Sun, et al.. (2023). Multi-omic analysis reveals metabolic pathways that characterize right-sided colon cancer liver metastasis. Cancer Letters. 574. 216384–216384. 13 indexed citations
2.
Hua, Guoqiang, Chu Wang, Yan Pan, et al.. (2017). Distinct Levels of Radioresistance in Lgr5+ Colonic Epithelial Stem Cells versus Lgr5+ Small Intestinal Stem Cells. Cancer Research. 77(8). 2124–2133. 44 indexed citations
3.
Martín, M. Laura, Zhaoshi Zeng, Mohammad Adileh, et al.. (2017). Logarithmic expansion of LGR5 + cells in human colorectal cancer. Cellular Signalling. 42. 97–105. 41 indexed citations
4.
Khan, Sajid, M. J. Morris, Kamran Idrees, et al.. (2016). Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients. Journal of Pediatric Surgery. 51(11). 1812–1817. 76 indexed citations
5.
Khan, Sajid, Zhaoshi Zeng, Jinru Shia, & Philip B. Paty. (2016). EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer. Pathology & Oncology Research. 23(3). 673–677. 25 indexed citations
6.
Loo, Jia Min, Alexander Nguyen, Ethan M. Weinberg, et al.. (2015). Extracellular Metabolic Energetics Can Promote Cancer Progression. Cell. 160(3). 393–406. 289 indexed citations
7.
Chiu, Thang Kien, Michael Fara, Jinru Shia, et al.. (2015). The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts. Journal of Translational Medicine. 13(1). 199–199. 45 indexed citations
8.
Cheng, Yu‐Wei, Hanna Pinças, Jianmin Huang, et al.. (2014). High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage. Medical Oncology. 31(11). 254–254. 9 indexed citations
9.
Karamurzin, Yevgeniy, Zhaoshi Zeng, Zsofia K. Stadler, et al.. (2012). Unusual DNA mismatch repair–deficient tumors in Lynch syndrome: a report of new cases and review of the literature. Human Pathology. 43(10). 1677–1687. 85 indexed citations
10.
Wen, Yong, Edi Brogi, Zhaoshi Zeng, et al.. (2012). DNA Mismatch Repair Deficiency in Breast Carcinoma. The American Journal of Surgical Pathology. 36(11). 1700–1708. 43 indexed citations
11.
Bachleitner‐Hofmann, Thomas, Mark Y. Sun, Chin‐Tung Chen, et al.. (2011). Antitumor Activity of SNX-2112, a Synthetic Heat Shock Protein-90 Inhibitor, in MET -Amplified Tumor Cells with or without Resistance to Selective MET Inhibition. Clinical Cancer Research. 17(1). 122–133. 33 indexed citations
12.
Forslund, Ann, Sajid Khan, Li‐Xuan Qin, et al.. (2010). Improved Testing for Microsatellite Instability in Colorectal Cancer Using a Simplified 3-Marker Assay. Annals of Surgical Oncology. 17(12). 3370–3378. 17 indexed citations
13.
Cheng, Yu‐Wei, Hanna Pinças, Manny D. Bacolod, et al.. (2008). CpG Island Methylator Phenotype Associates with Low-Degree Chromosomal Abnormalities in Colorectal Cancer. Clinical Cancer Research. 14(19). 6005–6013. 77 indexed citations
14.
Bacolod, Manny D., Shuang Wang, Richard Shattock, et al.. (2008). The Signatures of Autozygosity among Patients with Colorectal Cancer. Cancer Research. 68(8). 2610–2621. 40 indexed citations
15.
Khan, Sajid, Kamran Idrees, Ann Forslund, et al.. (2008). Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer. Journal of Surgical Oncology. 97(7). 621–625. 7 indexed citations
16.
Tsafrir, Dafna, Manny D. Bacolod, Zachariah Selvanayagam, et al.. (2006). Relationship of Gene Expression and Chromosomal Abnormalities in Colorectal Cancer. Cancer Research. 66(4). 2129–2137. 213 indexed citations
17.
Kammula, Udai S., Todd D. Francone, Zhaoshi Zeng, et al.. (2006). Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. Cancer Letters. 248(2). 219–228. 133 indexed citations
18.
Zeng, Zhaoshi, et al.. (2004). Immunoblot analysis of c-Met expression in human colorectal cancer: Overexpression is associated with advanced stage cancer. Clinical & Experimental Metastasis. 21(5). 409–417. 42 indexed citations
19.
Zeng, Zhaoshi, Yi Sun, Weiping Shu, & José G. Guillem. (2001). Tissue inhibitor of metalloproteinase-3 is a basement membrane-associated protein that is significantly decreased in human colorectal cancer. Diseases of the Colon & Rectum. 44(9). 1290–1296. 14 indexed citations
20.
Zeng, Zhaoshi, Zuo‐Feng Zhang, & Elin R. Sigurdson. (1995). Toxicity study of hepatic artery infusion chemotherapy with massive dose FUDR in rats. Surgical Oncology. 4(3). 147–155. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Pang Breakdown of academic impact, for papers by Camilla Pilati Breakdown of academic impact, for papers by Belinda Cancilla Breakdown of academic impact, for papers by Yoshihiko Kitajima Breakdown of academic impact, for papers by Kaoru Mogushi Breakdown of academic impact, for papers by M Imamura Breakdown of academic impact, for papers by Eric Santoni‐Rugiu Breakdown of academic impact, for papers by Binkui Li Breakdown of academic impact, for papers by Graham F. Barnard Breakdown of academic impact, for papers by Sara Toffanin
Rankless by CCL
2026